Reprint

Antimicrobial Prescribing and Stewardship, 1st Volume

Edited by
April 2023
372 pages
  • ISBN978-3-0365-7255-0 (Hardback)
  • ISBN978-3-0365-7254-3 (PDF)

This is a Reprint of the Special Issue Antimicrobial Prescribing and Stewardship, 1st Volume that was published in

Biology & Life Sciences
Medicine & Pharmacology
Summary

This Antimicrobial Prescribing and Stewardship Issue (volume 1) consist of manuscripts, including original research, review articles, case series, and opinion papers for topics related to antimicrobial (antibiotic, antifungal) stewardship, including:

Disease-based/organism-based antimicrobial stewardship;Diagnostic stewardship;Influence of antimicrobial utilisation changes in antimicrobial resistance;Impact of antimicrobial stewardship on quality performance measures and patient outcomes;Novel antimicrobial stewardship education and training approaches or interventions aimed at the public and/or healthcare workers;Behavioural change approaches to antimicrobial stewardship;Collaborative practice agreements in antimicrobial stewardship;Antimicrobial stewardship in special populations (e.g., paediatrics, geriatrics, emergency medicine, hematology/oncology);Tackling AMR through antimicrobial stewardship in low- and middle-income countries;Antimicrobial stewardship for animal health;Antimicrobial stewardship in alternative settings (e.g., community practice, long-term care, and resource-limited small and rural hospitals);Antimicrobial use and stewardship in the context of the COVID-19 pandemic;Global collaborations to tackle AMR through antimicrobial stewardship.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
antimicrobial stewardship; pharmacy; sepsis; wound management; culture and sensitivity testing; resistance patterns; low-and middle-income countries; Uganda; antibiotic; antimicrobial resistance; veterinary; animal health; Africa; antibiotic; bone infection; joint infection; osteomyelitis; pediatric infectious disease; septic arthritis; antibiotics; microbial resistance; upper respiratory tract infections; fosfomycin; urinary infection; resistance; CwPAMS App; smartphone apps; antimicrobial prescribing; pharmacy; antimicrobial resistance; antimicrobial stewardship; low- and middle-income countries; barriers and enablers; antimicrobial stewardship; training; antibiotics use; behavior change; Helicobacter pylori; antimicrobial stewardship; therapy; antibiotics; metronidazole; clarithromycin; fluoroquinolones; amoxicillin; proton pump inhibitors; ethical trials; obesity; bloodstream infection; antimicrobials; prescription; antimicrobial resistance; antimicrobial stewardship; community health workers; health practitioners; infection prevention and control; multidisciplinary; one health; Uganda; UK; antimicrobial resistance (AMR); antimicrobial stewardship (AMS); delayed/back-up prescribing; upper respiratory tract infections; developing countries; LMICs; Ghana; knowledge; attitudes; medical students; antimicrobial; stewardship; prescribing; antibiotics; meningitis; encephalitis; FilmArray; multiplex PCR; antimicrobial; rapid diagnostic technology; stewardship; children; adolescents; outcomes; antibiotic stewardship program; complementarity; prospective audit and feedback; antibiotic stewardship; pharyngitis; acute otitis media; clinical pathways; children; emergency departments; antibiotic use; prescribing appropriateness; follow-up blood cultures; Gram negative bacteremia; critically ill patients; antibiotic therapy; antimicrobial stewardship; general practice; family practice; antibiotic; health policy; quality of health care; antibiotics; public health; pharmacist; nurse; antimicrobial stewardship; COVID-19; pharmacy; antibiotic resistance; stewardship; wound care; burn care; Nepal; AMS; antimicrobial resistance; antimicrobial stewardship intervention; PDSA cycle; enterococcal; bacteremia; epidemiology; risk factors; mortality; antimicrobial stewardship; urinary tract infections (UTI); older adults; qualitative; leaflet; Theoretical Domains Framework; antimicrobial resistance; antibiotics; COVID-19; antimicrobial stewardship (AMS); antimicrobial resistance (AMR); coronavirus; SARS-CoV-2; antimicrobial stewardship; anti-infective agents; bacteremia; candidemia; hematologic diseases; antimicrobial stewardship; veterinary; complex intervention